The Influence of Cessation of Pomegranate Juice Intake on Inflammation and Oxidative Stress Markers and Glucose Control in Diabetic and Non Diabetic Chronic Hemodialysis Patients

Completed

• Conditions: Inflammation; Oxidative Stress
• Interventions: Other: No intervention

• Registration Number: NCT01033435
• Lead Sponsor: Western Galilee Hospital-Nahariya

Brief Summary

The current study will investigate chronic hemodialysis patients who were treated in our unit with pomegranate juice intake for 1 year - compared to a control group.

Markers will be taken 3 months after cessation of pomegranate juice intake, for inflammation and oxidative stress and Hb A1c.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-12
• Study First Submitted: 2009-12-15
• Study First Submitted QC: 2009-12-15
• Study First Posted: 2009-12-16
• Status Verified: 2011-08
• Study Completion: 2011-08
• Last Update Submitted: 2011-08-16
• Last Update Posted: 2011-08-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 49

Inclusion Criteria

• Chronic Hemodialysis patients three months after termination of study which is currently carried out at our unit; which compared patients taking pomegranate juice three times a week for 1 year to a group that received placebo juice.

Exclusion Criteria

• Patients who do not currently participate in above mentioned trial

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
chronic Hemodialysis patients, treated in our unit.	No intervention	-

Trial Locations

Locations (1)

Western Galilee Hospital; 🇮🇱 Nahariya, Western Galilee, Israel